K acetyltransferase 2B pseudogene (No canonical abbreviation.)

K acetyltransferase 2B pseudogene (LOC100420403, ENSG00000253160) is annotated as a pseudogene—a non-functional genomic DNA sequence similar to the functional lysine acetyltransferase 2B (KAT2B) gene. This locus contains sequence characteristics of a gene but does not encode a functional protein product, and there is no evidence that it acts as a therapeutic target, biomarker, or participates in biological pathways directly involved in disease, drug interaction, or cell biology. Pseudogenes are generally considered non-coding and do not play a functional role similar to their protein-coding counterparts. No published data support involvement of this locus in human disease or drug action. This entry is distinct from the functional lysine acetyltransferase 2B (KAT2B gene, ENSG00000114166), which is involved in histone acetylation, transcription regulation, and has established roles in development and disease[2][5]. The "pseudogene" designation specifically means the locus is not expected to produce an active, functional protein, and thus is not conventionally included in drug discovery or disease mechanism databases as a therapeutic target. No evidence exists of drug interaction, mechanism of action, biomarker utility, or disease linkage for this locus. The name as given is correct insofar as it represents standard genomic annotation for a pseudogene; however, it is not a therapeutic target and should not be confused with KAT2B or PCAF (protein-coding gene) entries. If you had intended the functional KAT2B gene (also known as PCAF, ENSG00000114166), please clarify, as the biological and therapeutic data pertain to that protein-coding gene, not this pseudogene.

Other names

LOC100420403ENSG00000253160